Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 8.85p
   
  • Change Today:
      0.000p
  • 52 Week High: 40.00
  • 52 Week Low: 8.00
  • Currency: UK Pounds
  • Shares Issued: 303.83m
  • Volume: 8,786
  • Market Cap: £26.89m
  • RiskGrade: 479
  • Beta: 0.08

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (2.93) (0.99)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (5.87) (1.83)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (6.87) (2.03)p n/a n/a n/a n/a 0.0%
31-Dec-23 3.10 (6.89) (2.21)p n/a n/a n/a n/a 0.0%
31-Dec-24 13.93 1.29 0.43p 73.6 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 12.27 1.50 0.58p 15.2 0.4 +35% n/a 0.0%
31-Dec-26 5.10 (2.58) (0.75)p n/a n/a +n/a n/a 0.0%
31-Dec-27 6.57 (0.69) (0.22)p n/a n/a +n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 73.60 73.60 n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Futura Medical Market Data

Currency UK Pounds
Share Price 8.85p
Change Today 0.000p
% Change 0.00 %
52 Week High 40.00
52 Week Low 8.00
Volume 8,786
Shares Issued 303.83m
Market Cap £26.89m
Beta 0.08
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.05% below the market average28.05% below the market average28.05% below the market average28.05% below the market average28.05% below the market average
91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average
Price Trend
93.86% below the market average93.86% below the market average93.86% below the market average93.86% below the market average93.86% below the market average
87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average
Income Not Available
Growth
22.56% above the market average22.56% above the market average22.56% above the market average22.56% above the market average22.56% above the market average
22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 28-May-2025

Time Volume / Share Price
08:00 7,376 @ 8.62p
08:00 2 @ 9.98p
08:00 101 @ 8.32p
08:00 698 @ 9.98p
08:00 58 @ 8.32p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page